Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia
Higher TTR and TATR were associated with better survival of critically ill patients with a severe course of COVID-19-associated pneumonia. Higher TBTR was associated with worse survival in these patients.
Authors
- Tereza Romanová (ORCID: https://orcid.org/0000-0001-6222-8922)
- Jan Máca (ORCID: https://orcid.org/0000-0002-9771-0468)
- Peter Sklienka (ORCID: https://orcid.org/0000-0002-0330-5323)
- Michal Burda (ORCID: https://orcid.org/0000-0002-4182-4407)
- Martin Pulcer (ORCID: https://orcid.org/0000-0003-4637-5222)
- Filip Burša (ORCID: https://orcid.org/0000-0001-9770-1433)
- Jiří Sagan (ORCID: https://orcid.org/0009-0000-8241-3308)
- Markéta Bílená
- Michelle Vaňková
- Denis Buršík
Institutions
- University of Ostrava (CZ)
- University Hospital Ostrava (CZ)
- Czech Academy of Sciences, Institute of Physiology (CZ)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/tcrm.s476187
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ostravská Univerzita v Ostravě